Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia.

MLA

Cozzi-Lepri, Alessandro, et al. “Development and Validation of a Prediction Score for Failure to Casirivimab/Imdevimab in Hospitalized Patients with COVID-19 Pneumonia.” Frontiers in Medicine, vol. 11, Mar. 2024, p. 1293431. EBSCOhost, https://doi.org/10.3389/fmed.2024.1293431.

APA

Cozzi-Lepri, A., Borghi, V., Rotundo, S., Mariani, B., Ferrari, A., Del Borgo, C., Bai, F., Colletti, P., Miraglia, P., Torti, C., Cattelan, A. M., Cenderello, G., Berruti, M., Tascini, C., Parruti, G., Coladonato, S., Gori, A., Marchetti, G., Lichtner, M., … Mussini, C. (2024). Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumonia. Frontiers in Medicine, 11, 1293431. https://doi.org/10.3389/fmed.2024.1293431

Chicago

Cozzi-Lepri, Alessandro, Vanni Borghi, Salvatore Rotundo, Bianca Mariani, Anna Ferrari, Cosmo Del Borgo, Francesca Bai, et al. 2024. “Development and Validation of a Prediction Score for Failure to Casirivimab/Imdevimab in Hospitalized Patients with COVID-19 Pneumonia.” Frontiers in Medicine 11 (March): 1293431. doi:10.3389/fmed.2024.1293431.